Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Specific depletion of alloreactive cytotoxic lymphocyte precursors

Abstract

THE major barrier to replacement therapy in various clinical immunodeficiency states is the likelihood that the transferred immunocompetent T lymphocytes would react against alloantigens of the recipient and produce graft-versus-host (GVH) disease1. The logical resolution of this problem would be to delete or inactivate those clones of T cells which are specifically coded to react against the histocompatibility antigens of the recipient tissues. The remaining cell population could then fully reconstitute the recipient without danger of GVH reactions. Specific clonal deletion of this kind has been obtained in experimental animal situations by pre-circulation through a third-party host2,3 or by induction of specific anti-idiotype immunity4. These studies show the validity of this approach but are technically complicated and have limited application. A simpler method of obtaining this result has been sought based on the following strategy. To reconstitute a strain A mouse by transfer of lymphocytes from an allogeneic strain B, the strain B lymphocytes are first incubated on a monolayer of cells of strain A. Those clones which recognise the strain A alloantigens should adhere to the monolayer; the non-adherent populations of cells should now be unable to react against alloantigens of strain A but should still respond to alloantigens of other haplotypes. Although this kind of technique has been widely effective in removing fully activated cytotoxic lymphocytes (Tc)5–9, its use to deplete alloreactive Tc precursors has given variable results8,10–16. Significant depletion of precursors has been reported primarily when the non-adherent cells have been assayed in vivo13–16, but this has been claimed to be due to change in the responder cells, not depletion, as the same population assayed by in vitro generation of Tc shows no evidence of depletion16. We present here a simple depletion method developed from our finding that when splenic lymphocytes are incubated for a few hours before being formed into a monolayer, they can effectively absorb alloreactive Tc precursors even when assayed by the sensitive in vitro assays.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Grebe, S. C. & Streilein, J. W. Adv. Immun. 22, 119–221 (1976).

    Article  CAS  Google Scholar 

  2. Ford, W. L. & Atkins, R. C. Nature new Biol. 234, 178–180 (1971).

    Article  CAS  Google Scholar 

  3. Bennink, J. R. & Doherty, P. C. J. exp. Med. 148, 128–135 (1978).

    Article  CAS  Google Scholar 

  4. Binz, H. & Wigzell, H. Nature 262, 294–295 (1976).

    Article  ADS  CAS  Google Scholar 

  5. Berke, G. & Levey, R. H. J. exp. Med. 135, 972–984 (1972).

    Article  CAS  Google Scholar 

  6. Stulting, R. D. & Berke, G. J. exp. Med. 137, 932–942 (1973).

    Article  CAS  Google Scholar 

  7. Kedar, E., Ortiz de Landazuri, M., Bonavida, B. & Fahey, J. L. J. immun. Meth. 5, 97–102 (1974).

    Article  CAS  Google Scholar 

  8. Neefe, J. R. & Sachs, D. H. J. exp. Med. 144, 996–1008 (1976).

    Article  CAS  Google Scholar 

  9. Chisholm, P. M. & Ford, W. L. Eur. J. Immun. 8, 438–445 (1978).

    Article  CAS  Google Scholar 

  10. Clark, W. & Kimura, A. Nature new Biol. 235, 236–237 (1972).

    Article  CAS  Google Scholar 

  11. Altman, A., Cohen, I. R. & Feldman, M. Cell Immun. 7, 134–142 (1973).

    Article  CAS  Google Scholar 

  12. Bach, F. H. et al. Science 180, 403–406 (1973).

    Article  ADS  CAS  Google Scholar 

  13. Lonai, P., Eliraz, A., Wekerle, H. & Feldman, M. Transplantation 15, 368–374 (1973).

    Article  CAS  Google Scholar 

  14. Bonavida, B. & Kedar, E. Nature 249, 658–659 (1974).

    Article  ADS  CAS  Google Scholar 

  15. Mage, M. G. & McHugh, L. L. J. Immun. 115, 911–913 (1975).

    CAS  PubMed  Google Scholar 

  16. Kedar, E., Clark, W. R. & Bonavida, B. Transplantation 25, 146–151 (1978).

    Article  CAS  Google Scholar 

  17. Bach, F. H., Bach, M. L. & Sondel, P. M. Nature 259, 273–281 (1976).

    Article  ADS  CAS  Google Scholar 

  18. Leben, M. L. & Boyle, W. Transplantation 24, 201–210 (1977).

    Article  CAS  Google Scholar 

  19. Schnagl, H. Y. & Boyle, W. J. immun. Meth. 24, 79–88 (1978).

    Article  CAS  Google Scholar 

  20. Smart, I. J., Boyle, W. & Morris, P. J. Tissue Antigens 11, 20–29 (1978).

    Article  CAS  Google Scholar 

  21. Janeway, C. A., Wigzell, H. & Binz, H. Scand. J. Immun. 5, 993–1001 (1976).

    Article  CAS  Google Scholar 

  22. Bach, F. H. et al. Cold Spring Harb. Symp. quant. Biol. 41, 429–441 (1976).

    Article  Google Scholar 

  23. Lafferty, K. J. & Woolnough, J. Immun. Rev. 35, 231–262 (1977).

    Article  CAS  Google Scholar 

  24. Boyle, W., Kelso, A. & Leben, M. L. Nouv. Rev. Hemat. (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

SCHNAGL, H., BOYLE, W. Specific depletion of alloreactive cytotoxic lymphocyte precursors. Nature 279, 331–333 (1979). https://doi.org/10.1038/279331a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/279331a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing